Hepatitis due to Enterovirus in a Child Authors: Anna Prete, Sergio Di Fenza, Claudia Mandato, Giovanna D'Urzo, Pasquale Villano, Maria Amendolara, Anna M. Aurino, Marco F. Natale, Antonella De Santis, Giuseppe Avallone, Luigi Masini Published: 2025 ABSTRACT ABSTRACTEnteroviruses are a common cause of infection in neonates, causing wide spectrum of diseases, including myocarditis, myelitis, meningoencephalitis, hepatitis, and sepsis. The enteroviral hepatitis has rarely been recorded in pediatric populations other than neonates. We report a rare case of self-limiting acute hepatitis in a healthy 3-year-old child affected by hand-foot-and-mouth disease caused by Enterovirus. Providers should be aware of hepatitis prevalence in the Enteroviral infection, and should consider it in the differential diagnosis for acute hepatitis of unknown origin. INTRODUCTION Viral causes of hepatitis are well known in both adults and children. The most common causes of acute viral hepatitis include hepatitis A and B. Other viruses have also been known to cause acute hepatitis at a young age, including Epstein-Barr virus, Cytomegalovirus, Herpes simplex virus, and Enterovirus. According to the data from the Center for Disease Control and Prevention in America, nonpolio-Enteroviruses cause 10–15 million infections and tens of thousands of hospitalizations in the United States each year.1 Asymptomatic infections account for approximately 50% of the cases, while symptomatic Enteroviral infections range from nonspecific febrile illnesses to life-threatening diseases such as myocarditis or sepsis, and in newborn infants fulminant hepatitis.2–4 However, the main manifestations include hand-foot-mouth disease, acute hemorrhagic conjunctivitis, herpangina, etc.5 Enteroviral hepatitis has rarely been recorded in populations other than neonates, so the aim of this paper was to present a rare case of hepatitis due to Enterovirus in a child. CASE REPORT A previously healthy 3-year-old boy initially presented to our hospital with febrile seizure and malaise. He had no contact with a sick person, history of travel or use of medications, and family history was noncontributory. He was born full term by cesarean section due to previous cesarean sections, with birth weight of 3,450 kg, and his immunization status was complete and up-to-date. There was no significant pre-, peri- or postnatal complications in the child and the mother. On admission, he presented hyperemic pharynx and tonsillar exudate, there was no abdominal pain, no jaundice or scleral icterus. All other portions of the physical examination were within normal limits. No changes in mental status or in hemodynamic parameters were observed. During the fourth day of stay at the hospital, he developed erythematous papular eruptions on the hands, feet and mouth, and perioral vesicles. From the first day, the patient was treated symptomatically with intravenous (IV) fluids, acetaminophen for fever control, and empirical antibiotic therapy with IV ampicillin-sulbactam, because of neutrophilic leukocytosis and tonsillar exudate. Initial laboratory testing showed leukocytosis of 14.5 K/µL (neutrophils 77.8%), lactate dehydrogenase 692 U/L, and elevated liver enzymes including alanine transaminase (ALT) 590 U/L, aspartate aminotransferase (AST) 559 U/L, and γ-Glutamyltranspeptidase (γ- GT) 115 U/L. Alkaline phosphatase (ALP) and total bilirubin were normal at 74 U/L and 0.35 mg/dL respectively. Prothrombin time, international normalized ratio, lipase, and urinalysis were within normal limits. All pertinent laboratory results on admission can be found in Table 1. An abdominal ultrasound, an electrocardiogram, and a transthoracic echocardiogram without abnormalities were obtained in the first day of stay. Table 1.Initial laboratory testing valuesLaboratory testSubtestResultNormalComplete blood countWBC14.5 K/μL4.5–13RBC4.41 M/μL4–4.7HGB12.2 g/dL10–16HCT37.1%36–43MCV84.2 fL70–80MCH27.7 pg26–30MCHC32.9 g/dL32–36RBC distribution15.8%11.5–15.5Absolute neutrophils11.28 K/μL1.8–7.8Absolute lymphocytes1.96 K/μL1.35–6.50Absolute monocytes0.81 K/μL0.13–1.04Absolute eosinophils0.16 K/μL0.04–0.52Absolute basophils0.09 K/μL0–0.13PLT368 K/μL150–400Pancreatic functionLipase37 U/L8–57Complete metabolic panelAST559 U/L0–40ALT590 U/L0–41γ- GT115 U/L7–50Blood urea nitrogen20 mg/dL10–50Glucose74 mg/dL60–110Sodium131 mg/dL136–145Potassium5.0 mg/dL3.5–5.5Chloride98 mmol/L90–110Calcium9.8 mg/dL8.4–10.4Total protein7.1 g/dL6.6–8.7Albumin4.7 g/dL3.4–5.42Bilirubin total0.35 mg/dL0.1–1.2Alkaline phosphatase286 U/L30–300Creatinine0.26 mg/dL0.7–1.2C-Reactive protein1.3 mg/L0–5Procalcitonin0.20 ng/mL0.02–0.20Ferritin76 ng/mL30–400Total cholesterol152 mg/dL120–200Triglycerides86 mg/dL20–200Lactate dehydrogenase290 U/L135–250Troponin T3 pg/mL0–15IgA180 mg/dL20–100IgM121 mg/dL19–146IgG1,019 mg/dL453–916CoagulationProthrombin time13.2 sINR1.150.8–1.2γ- GT, γ-Glutamyltranspeptidase; ALT, alanine transaminase; AST, aspartate aminotransferase; HCT, hematocrit; HGB, hemoglobin; Ig, immunoglobulin; INR, international normalized ratio; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; PLT, platelets; RBC, red blood cell; WBC, white blood cell. Initial laboratory testing values γ- GT, γ-Glutamyltranspeptidase; ALT, alanine transaminase; AST, aspartate aminotransferase; HCT, hematocrit; HGB, hemoglobin; Ig, immunoglobulin; INR, international normalized ratio; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; MCV, mean corpuscular volume; PLT, platelets; RBC, red blood cell; WBC, white blood cell. Laboratory testing of blood, urine, stool, and respiratory samples for possible underlying infectious process were obtained as detailed in Tables 2–4. The patient did have positive hepatitis B surface immunoglobulin G, likely reflecting previous immunization after vaccination. Table 2.Set of microbiological testsTestResultNormalCytomegalovirus IgMNegativeNegative IgG<5.00 U/mL0–12Herpes simplex virus IgM<0.5 U/mL0–0.9 IgG<0.5 U/mL0–0.9 Toxoplasma gondii IgM<3.00 U/mL0–7.2 IgGNegativeNegativeRubeolavirus IgMNegativeNegative IgG<5.00 U/mL0–12Vidal wright test<1:40<1:40Blood culturesNegativeNegativeUrinary culturesNegativeNegativeStool culturesNegativeNegativeThroat swab cultureNegativeNegativeIgG, Immunoglobulin G; IgM, Immunoglobulin M Set of microbiological tests IgG, Immunoglobulin G; IgM, Immunoglobulin M Table 3.Hepatitis panelTestResultNormalHepatitis A IgM antibodyNegativeNegativeHepatitis B surface antigenNegativeNegativeHepatitis B surface antibodyPositiveNegativeHepatitis B core IgM antibodyNegativeNegativeHepatitis C antibodyNegativeNegative Hepatitis panel Table 4.Polymerase chain reaction multiplex respiratory panel assay from nasopharyngeal swabVirusResultAdenovirusNot detectedCoronavirus 229ENot detectedCoronavirus HKU1Not detectedCoronavirus NL63Not detectedCoronavirus OC43Not detectedMiddle east respiratory syndrome coronavirus (MERS-CoV)Not detectedSevere acute respiratory syndrome coronavirus (SARS-CoV-2)Not detectedHuman MetapneumovirusNot detectedEnterovirusDetectedInfluenza ANot detectedInfluenza BNot detectedParainfluenza virus 1Not detectedParainfluenza virus 2Not detectedParainfluenza virus 3Not detectedParainfluenza virus 4Not detectedRespiratory syncytial virusNot detectedBordetella parapertussisNot detectedBordetella pertussisNot detectedChlamydia pneumoniaeNot detectedMycoplasma pneumoniaeNot detected Polymerase chain reaction multiplex respiratory panel assay from nasopharyngeal swab Enterovirus was positive via polymerase chain reaction (PCR) from nasopharyngeal swab, and confirmed via real-time PCR from blood sample (Tables 4 and 5). Additional workup for other liver pathologies was negative, including alpha-1 antitrypsin, ferritin and iron studies, and ceruloplasmin. Records of autoimmune panel revealed positive antinuclear antibody with 1:160 titer, however anti-smooth muscle and anti-mitochondrial antibodies, anti-tissue transglutaminase antibody were negative. No additional markers of autoimmune hepatitis were tested. The clinical workup suggested a final diagnosis of acute hepatitis secondary to Enteroviral infection, so gastroenterologist was consulted to aid in the assessment of the patient's condition and his care. Table 5.Real-time polymerase chain reaction viral panel from blood sampleVirusResultU.M.NormalHerpes simplex virus 1 - DNANegativeCopies/mLNegativeHerpes simplex virus 2 - DNANegativeAUNegativeVaricella zoster virus - DNANegativeCopies/mLNegativeEpstein Barr virus - DNANegativeCopies/mLNegativeCytomegalovirus - DNANegativeCopies/mLNegativeHerpes virus 6 - DNANegativeAUNegativeHerpes virus 7 - DNANegativeAUNegativeAdenovirus - DNANegativeAUNegativeEnterovirus - RNAPositive – 47 AUAUNegativeParechovirus - RNANegativeAUNegativeAU, arbitrary units. Real-time polymerase chain reaction viral panel from blood sample AU, arbitrary units. On hospital day 7, AST increased to 761 U/L, ALT to 691 U/L, ALP to 355 U/L, and γ-GT to 161 U/L, whereas total bilirubin, albumin, and international normalized ratio/prothrombin time were within normal limits. In the following days, the patient was improving symptomatically, and liver function tests (LFTs) were down trending. On hospital day 14, AST decreased to 33 U/L, ALT to 84 U/L, ALP to 271 U/L, and γ-GT to 102 U/L. Trend of LFTs, including ALT, AST, γ-GT and ALP, are given in Table 6. At day 21, his LFTs returned to baseline, the patient was stable and discharged with instructions to take acetaminophen no more than 1,000 mg in a 24-hours period for pain/fever relief if needed. He obtained a follow-up complete metabolic panel every 3 days until 28 days from admission to ensure LFT improvement, and a follow-up with hepatology outpatient. Table 6.Trend of liver function testsALTASTγ- GTALPDay 159055911574Day 7691761161355Day 148433102271γ- GT, γ-Glutamyltranspeptidase; ALT, alanine transaminase; ALP, Alkaline phosphatase; AST, aspartate aminotransferase. Trend of liver function tests γ- GT, γ-Glutamyltranspeptidase; ALT, alanine transaminase; ALP, Alkaline phosphatase; AST, aspartate aminotransferase. DISCUSSION Enteroviruses are major pathogens in neonates, but in children 90 percent of these infections are nonsymptomatic or manifest simply as an undifferentiated febrile illness.6 These viruses were traditionally classified into the following 4 subgenera: poliovirus, coxsackievirus A and B, and echovirus. In infants, these pathogens can cause varied clinical manifestations, including hand-foot-and-mouth disease, respiratory illness, myocarditis, meningitis, sepsis, and even lethal multisystem organ failure.7–9 Echoviruses particularly may cause severe hepatitis with foci of hepatic necrosis.10 Coxsackievirus group A is well-known to cause hand-foot-and-mouth disease in children, characterized by fever and erythematous papular eruptions on the hands, feet, and mouth, whereas Coxsackie B is known to cause myocarditis, meningitis, and hepatitis in children and neonates.11–13 In our case, real-time-PCR did not discriminate the Enterovirus serotypes, but we can hypothesize a Coxsackievirus group A etiology, due to the typical features of hand-foot-mouth disease showed by the patient. Very few cases of Enteroviral infection causing abnormal liver function in pediatric patients have been reported, in particular only Qizalbash et al in 2018 reported a pediatric case of hepatitis and meningoencephalitis due to Enterovirus during hand-foot-mouth disease.14,15 Another case of hepatitis due to Coxsackievirus A was reported in 2025 by Surendra et al, but in an adult with underlying liver vulnerability.16 Like these cases, our patient had a similar self-limiting hepatitis during an enteroviral infection, but ours is a unique case of hepatitis manifested in absence of underlying liver damage and during a common paucisymptomatic disease, admitted and evaluated for laboratory testing owing to the febrile seizure. In summary, we have presented a rare pediatric case of hepatitis due to Enterovirus with the typical manifestations of hand-foot-and-mouth disease, with more severe symptoms characterized by febrile seizure and malaise. In our case, elevated LFTs reflect damage to the liver cells in a healthy child without previous liver illness. Despite the benign course of hepatitis, the acute liver injury complicated the course of a self-limiting disease, requiring a long hospital stay and outpatient serological and clinical follow-up. The incidence of hepatitis during a common hand-foot-and-mouth disease is unknown, because most of children are managed as outpatients. We can hypothesize many patients with paucisymptomatic enteroviral infection may have an unknown self-limiting hepatitis. Following this case report, providers should consider the Enteroviruses in the differential diagnosis for acute hepatitis of unknown origin, and evaluate liver function in the Enteroviral infection with more severe symptoms. DISCLOSURES Author contributions: Clinical management and clinical decision-making: L. Masini, M. Amendolara, AM Aurino, G. Avallone. Consultant pediatric hepatologist: C. Mandato. Data curation: G. D'Urzo, MF Natale, A. De Santis, P. Villano. Writing—original draft: A. Prete, S. Di Fenza. Writing—review and editing: A. Prete, S. Di Fenza. A. Prete is the article guarantor. Financial disclosure: None to report. Informed consent was obtained for this case report.